There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...
Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...
((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...
Opens in a new tab or window The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on ...
Although there is no cure for COPD and new drugs still need to be developed, current treatment options such as statins may still benefit more patients if caregivers become more aware of their ...
Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...
These drugs, which open airways and reduce swelling, are a cornerstone of COPD treatment, making inhaler devices and medications the talk of the town at the Congress’ ERS panels and symposia.
Dupixent is an “add-on” drug for COPD, meaning patients take it in addition to inhaled medication Dupixent isn’t approved as a stand-alone treatment for COPD. The U.S. Food and Drug ...
Dupilumab, an injectable interleukin (IL)-4 and IL-13 pathway inhibitor, recently received FDA approval as the first-ever ...
The approval makes COPD the sixth indication for the blockbuster treatment and makes Dupixent the first available biologic for the condition. As per a 27 September press announcement, Dupixent ...
This approval was based on results from the phase 3 BOREAS (NCT03930732) and NOTUS (NCT04456673) trials, which demonstrated that dupilumab can significantly reduce COPD exacerbations. 2 The first ...
The drug, Dupixent, showed a reduction of at least 30% in the annualized rate of moderate or severe COPD in a pair of Phase 3 studies. The drug was previously approved for the treatment of other ...